Immunotherapy Boosted Survival in Anaplastic Thyroid Cancer Is Short Lived

she said.

“Targeted therapy and immunotherapy should be considered strongly when treating patients with ATC,” she said. “But we have to consider the adverse effects that patients experience, and there should be a discussion of a possible plateau in effects of targeted therapy.” 

Thomas R. Collins is a freelance medical writer based in Florida.